SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Patients With Atherosclerotic Heart Disease or at Risk for Congestive Heart Failure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Differential Indication for SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in Patients With Established Atherosclerotic Heart Disease or at Risk for Congestive Heart Failure
Metab. Clin. Exp. 2019 Dec 07;[EPub Ahead of Print], F Giorgino, I Caruso, J Moellmann, M LehrkeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.